precisionmedicineonline1h
Class Action Securities Lawsuit Against Allarity Therapeutics Dismissed
Shareholders sued Allarity over alleged false statements about the prospects for approval of the firm's investigational kidney cancer therapy.
precisionmedicineonline23h
University of Wisconsin Investigators Testing First Cell Therapy for Patients With Severe Dry Mouth
The first patient, who had xerostomia linked with Sjögren's disease, received the autologous cell therapy as part of a Phase ...
precisionmedicineonline3h
FDA Grants Priority Review to Precigen's Recurrent Respiratory Papillomatosis Gene Therapy
If approved, PRGN-2012 would be the first treatment allowed by the FDA for the rare and chronic disease caused by HPV 6 and HPV 11.